Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/6270
Full metadata record
DC FieldValueLanguage
dc.contributor.authorElango, Rajavel-
dc.date.accessioned2024-09-24T07:25:17Z-
dc.date.available2024-09-24T07:25:17Z-
dc.date.issued2023-04-14-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/6270-
dc.description.abstractABSTRACT Individual amino acids are widely popular as supplements because of various perceived and real health benefits. However, currently, there are no recommendations set by national health agencies for tolerable upper intake levels (UL) for amino acids because of a lack of wellconducted human dose-response trials. In the past decade, under the initiative of the International Council on Amino Acid Science, a nonprofit organization, a series of UL human clinical studies were conducted. The goal of this narrative review is to summarize the studies on 6 essential amino acids (leucine, tryptophan, methionine, lysine, histidine, and phenylalanine), 2 nonessential amino acids (arginine and serine), and 2 nonproteinogenic amino acids (ornithine and citrulline) and provide the first set of ULs. A brief background of the concept of the DRI framework of UL, the concept of UL for amino acids, and a perspective of the results are also provided. The data suggest that in relatively healthy adult individuals, the tested amino acids are well tolerated, and ULs, or the no-observed-adverse-effect-level (NOAEL), lowest-observed-adverse-effect-level (LOAEL), can be determined. The ULs were for leucine—young (35 g/d), tryptophan (4.5 g/d), and leucine—elderly (30 g/d); NOAEL and LOAEL for methionine at 3.2 and 6.4 g/d, respectively; NOAEL for arginine (30 g/d); NOAEL and LOAEL for lysine at 6 and 7.5 g/d, respectively; NOAEL and LOAEL for histidine at 8 and 12 g/d, respectively; and NOAEL for phenylalanine (12 g/d), serine (12 g/d), ornithine (12 g/d) and citrulline (24 g/d). This first set of human UL data are hoped to help national and international agencies set safety standards for supplemental amino acids. Keywords:en_US
dc.language.isoenen_US
dc.publisherAdvances in Nutritionen_US
dc.subjecttolerable upper intake level,en_US
dc.subjectamino acids,en_US
dc.subjecthumans,en_US
dc.subjectleucine,en_US
dc.subjectmethionineen_US
dc.titleTolerable Upper Intake Level for Individual Amino Acids in Humans: A Narrative Review of Recent Clinical Studiesen_US
dc.typeArticleen_US
Appears in Collections:VOL 14 No 4 2023

Files in This Item:
File Description SizeFormat 
20. Tolerable-Upper-Intake-Level-for-Individual-Amino-.pdf552.79 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.